inbox/queue/2025-10-02-kiutra-he3-free-adr-commercial-deployment.md

@@ -7,9 +7,13 @@ date: 2025-10-02
 domain: space-development
 secondary_domains: []
 format: article
-status: unprocessed
+status: null-result
 priority: medium
 tags: [helium-3, adr, quantum-computing, cryogenics, commercial-deployment, kiutra, substitution]
+processed_by: astra
+processed_date: 2026-03-19
+extraction_model: "anthropic/claude-sonnet-4.5"
+extraction_notes: "LLM returned 0 claims, 0 rejected by validator"
 ---
 
 ## Content
@@ -49,3 +53,13 @@ PRIMARY CONNECTION: Pattern 4 He-3 demand robustness — most direct evidence th
 WHY ARCHIVED: Commercial deployment at research institutions is the key fact — this moves ADR from speculative to proven-in-limited-context. The remaining question is scale-up to data-center quantum computing.
 
 EXTRACTION HINT: Extract as "experimental" confidence claim — ADR is proven at research scale, not yet at commercial quantum computing scale. The extractor should acknowledge kiutra's deployment while noting the scale gap to Interlune's target market.
+
+
+## Key Facts
+- Kiutra raised €13M ($15.2M) in October 2025
+- Round led by NovaCapital (Italy) and 55 North (Denmark), with HTGF (Germany)
+- Total funding exceeds €30M
+- Kiutra is based in Munich, Germany
+- He-3 is produced primarily from tritium decay in US and Russian nuclear stockpiles
+- He-3 supply constraints have affected experimental physics for 15+ years
+- NATO and EU have flagged He-3 as a quantum technology supply chain risk